The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 04, 2020
Filed:
Jun. 16, 2016
Applicant:
Hexal Aktiengesellschaft, Holzkirchen, DE;
Inventors:
Assignee:
Hexal AG, Holzkirchen, DE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/28 (2006.01); A61K 9/16 (2006.01); A61K 31/513 (2006.01); A61K 31/155 (2006.01); A61K 31/4439 (2006.01);
U.S. Cl.
CPC ...
A61K 9/2866 (2013.01); A61K 9/1617 (2013.01); A61K 9/1623 (2013.01); A61K 9/1652 (2013.01); A61K 9/1682 (2013.01); A61K 31/155 (2013.01); A61K 31/4439 (2013.01); A61K 31/513 (2013.01);
Abstract
The present invention belongs to the field of pharmaceutical industry and relates to a pharmaceutical composition comprising an intragranulate phase and an extragranulate phase, wherein the pharmaceutically active ingredient (API) 2-({6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl}methyl)benzonitrile or a pharmaceutically acceptable salt thereof, is present in the intragranulate phase, wherein said intragranulate phase is free from microcrystalline cellulose. Further, the present invention relates to a process for preparing the same.